Lucerno Dynamics

Executive Summary

Lucerno Dynamics is a Raleigh-based digital health company dedicated to improving the safety and efficacy of nuclear medicine procedures. Its flagship product, the Lara® System, provides real-time monitoring to detect and quantify radiopharmaceutical extravasations—a common injection error where the radioactive tracer leaks into surrounding tissue. By alerting clinicians immediately, the system enables prompt corrective action, reducing patient harm and improving diagnostic accuracy. The company addresses a critical but often overlooked safety issue in nuclear medicine, positioning itself as a key player in the diagnostic imaging value chain. With a strong focus on quality improvement and regulatory compliance, Lucerno Dynamics is well-positioned for growth as healthcare systems prioritize patient safety and operational efficiency. The company's technology has the potential to become standard of care, driven by increasing awareness and adoption among nuclear medicine departments.

Upcoming Catalysts (preview)

• Q4 2026FDA Clearance of Next-Generation Lara System80% success
• Q3 2026Publication of Clinical Study Demonstrating Improved Outcomes70% success
• Q2 2027Partnership with Major Hospital Network for System-Wide Deployment60% success